Migraine Minute News Update
The Migraine Minute provides weekly updates in migraine research and news hosted by Molly O'Brien of the Association of Migraine Disorders.
info_outline
Making OnabotulinumtoxinA Injections Less Painful
07/17/2026
Making OnabotulinumtoxinA Injections Less Painful
Ever wonder if there was a way to make OnabotulinumtoxinA injections less painful? New research suggests using this treatment before injections may help. Molly O’Brien explains in this Migraine Minute news update. Read the study: Script: For many people with chronic migraine, onabotulinumtoxinA, also known as Botox, is an effective treatment, but it can come with injection pain and post-treatment headache. New research shows there may be an option to help ease that pain. A study published in HEADACHE, found that adults who used a REN, or Remote Electrical Neuromodulation device, felt less pain during injections. The study also found that only 15 percent of those who used the REN device reported post-treatment headache, compared with 55 percent of those who used the fake device. The REN is sold under brand name Nerivio. It’s a wearable, drug-free device that delivers electrical pulses to the arm, triggering the body's natural pain relief process. Researchers say these results show Remote Electrical Neuromodulation could be a safe and easy way to make injection treatment sessions more comfortable.
/episode/index/show/migraineminute/id/41826850
info_outline
4th of July Migraine Triggers & Tips
07/03/2026
4th of July Migraine Triggers & Tips
Celebrating the Fourth of July with migraine is not easy. This festive holiday can be packed with sensory overload and migraine triggers. In this Migraine Minute, Molly O’Brien shares tips to help you enjoy the celebration while protecting your health. Check out our triggers webpage: Script: While the Fourth of July can be a fun holiday to celebrate in the States, it can be tough for folks with migraine. Why? Well, there are so many factors that can be stacked against you. Think about it, heat, big crowds, staying up late, BBQ foods and drinks that might have triggering ingredients…Not to mention the bright flashes and loud bangs of fireworks. Research even shows exposure to sulfur dioxide, a common byproduct of fireworks, may trigger migraine attacks. If you have migraine and still want to enjoy the holiday, here are some tips from our migraine community: Stay hydrated, wear earplugs, watch fireworks from afar or skip altogether, bring migraine-safe food and drinks to your cookout, wear sunglasses or migraine glasses and keep a consistent routine. Don’t forget to check out AMD’s updated triggers page, where you can learn more about common migraine triggers and how to manage them.
/episode/index/show/migraineminute/id/41680265
info_outline
Here’s Why Fighting Migraine Stigma Matters
06/12/2026
Here’s Why Fighting Migraine Stigma Matters
Why does fighting migraine stigma matter? That stigma we face may be more harmful than many people realize. Research shows increased stigma is linked with higher disease burden. Molly O'Brien breaks it all down in this Migraine Minute News Update. Read the study: Script: June is Migraine and Headache Awareness Month, and you’re likely going to hear a lot about fighting migraine stigma. Let’s take a look at why it really matters. Stigma is when someone is judged, dismissed, or treated unfairly because of a trait or condition. Through research, we’re learning how harmful migraine stigma can be. According to the OVERCOME study, more than 30 percent of those living with migraine said they experience migraine stigma often or very often. The study found that increased migraine stigma was linked with higher disability, more burden between attacks, and lower quality of life, regardless of how many monthly headache days someone has. Researchers say the social context of migraine might actually have a bigger impact on quality of life than the number of headache days! With that, fighting stigma and spreading migraine awareness may help better the lives of all of us living with migraine.
/episode/index/show/migraineminute/id/41599930
info_outline
Migraine & Tension Headache Linked With Body Pain
05/29/2026
Migraine & Tension Headache Linked With Body Pain
A new study shows body pain is more common and widespread in people with migraine or tension-type headache, and may be linked to a greater disease burden. Molly O’Brien breaks down the study in this Migraine Minute News Update. Read more: Script: According to a study published in the Journal of Headache and Pain, body pain is more prevalent and widespread in people with either migraine or tension-type headache. Researchers in South Korea wanted to better understand the relationship between headache and body pain. They reviewed data from 1,870 people, finding that those with migraine or tension-type headaches reported more body pain than those without. The location of pain differed between groups. Migraine was linked with neck pain, while tension-type headache showed a link to upper back pain. The study also found that the more widespread and intense the body pain, the greater the headache burden, including more frequent and severe monthly headache days, lower quality of life, along with more depression, anxiety, and insomnia. Researchers say the findings may point to central sensitization, where the brain and spinal cord become overly sensitive to pain signals.
/episode/index/show/migraineminute/id/41166740
info_outline
Migraine Days Drop in Kids Treated With Fremanezumab
05/15/2026
Migraine Days Drop in Kids Treated With Fremanezumab
According to a study in the New England Journal of Medicine, fremanezumab led to a greater reduction in migraine days per month than placebo in children and adolescents with episodic migraine. Molly O’Brien breaks down the study in this Migraine Minute News Update. Read the study: Script: In August of 2025, the FDA approved fremanezumab, sold under brand name Ajovy, for prevention of episodic migraine in kids aged 6 to 17 who meet weight requirements. Now we’re getting a look at additional research that supports how effective the drug is. Over the course of three months, 123 young people received a once-per-month injection of fremanezumab, while the other 111 participants got the placebo. According to the study, published in the New England Journal of Medicine, participants who received fremanezumab had fewer migraine days than those in the placebo group. They also had fewer moderate to severe headache days. Nearly half of the group taking the treatment saw at least a 50 percent drop in migraine days… The most common side effect was redness at the injection site. Study authors say a longer follow-up is needed to better understand safety and how well the drug works in kids and teens.
/episode/index/show/migraineminute/id/41166335
info_outline
Migraine + Fatigue: What New Research Reveals
05/01/2026
Migraine + Fatigue: What New Research Reveals
Feeling drained with migraine? New research shows that more than half of people with migraine report fatigue, and it’s tied to more frequent attacks and greater disability. Molly O’Brien breaks down the details in this Migraine Minute news update. Read More: Script: More than half of people living with migraine say they also struggle with fatigue. That’s according to a new study published in BMC’s Journal of Headache and Pain. The study included 2,403 migraine patients, 57 percent of whom reported fatigue. They also found that people with fatigue had higher migraine frequency, worse sleep more disability, more severe cognitive symptoms, and more symptoms of anxiety and depression, compared to those who didn’t.* Study authors say that because fatigue is so common and impactful in migraine, it needs more attention. They suggested screening should be part of evaluations. *Although the study did not specify the exact cognitive symptoms, common ones people often experience include brain fog, memory problems, or trouble focusing.
/episode/index/show/migraineminute/id/40713360
info_outline
Insurance Restrictions on Migraine Drugs Drive Higher ER Use
04/17/2026
Insurance Restrictions on Migraine Drugs Drive Higher ER Use
Insurance hurdles like prior authorization and step therapy prevent migraine patients from finding relief, but could payer blocking strategies lead to more ER and hospital visits? Molly O’Brien breaks it down the latest in this Migraine Minute news update. Read the study: The Migraine Policy Forum: Script: A study published in Headache shows insurance restrictions that deny access to migraine treatments aren’t just frustrating…. These so-called “payer blocking” strategies were linked to more ER visits and hospital stays. Researchers reviewed information from more than 370,000 people with migraine who were denied access to prescribed migraine drugs at least two times because of payer blocking insurance restrictions like step therapy or prior authorization. They found payer blocking affected about one in five patients and was more common among those with lower income or lower education levels. They also found people with a history of payer blocking were more likely to visit the ER or be hospitalized for migraine-related or other health issues. Lead author Dr. Dawn Buse said, “These insurance barriers don't just delay care, they undermine quality of life, especially for those with fewer resources. Reducing them is essential to improving migraine outcomes."
/episode/index/show/migraineminute/id/40711245
info_outline
Study Shows Migraine More Common in People with Autism
04/03/2026
Study Shows Migraine More Common in People with Autism
As April is Autism Awareness Month, we’re sharing new research on the relationship between migraine and autism. A study published in Headache shows people with autism are more likely to experience migraine or headache, and symptoms may be more severe. breaks it down in this Migraine Minute news update. Read the Study: Creative Commons: Script: A study published in Headache found that people with autism are more likely to also have headache or migraine than those without autism. Looking at two data sets, researchers found that headache and migraine severity were increased in people with autism compared to those without. Also of note, people with autism and migraine were more likely to have had negative experiences in childhood, such as bullying, being a victim of violence, poor health, anxiety, depression, and concussion. Researchers note that migraine may be underdiagnosed in those living with autism due to communication barriers and that migraine screening may help with earlier diagnosis and treatment in those with autism.
/episode/index/show/migraineminute/id/40700575
info_outline
Sinus Infection or Migraine? New HEADS Registry Findings
03/20/2026
Sinus Infection or Migraine? New HEADS Registry Findings
Facial pain or pressure? It might not be a sinus infection. New findings from AMD’s HEADS Registry suggest migraine may be behind these symptoms for some. Molly O’Brien breaks down the research in this Migraine Minute News Update. Read more: Do you have sinus pain, dizziness, or ringing in the ears? The HEADS Registry is collecting patient experiences to improve care. Learn more: Creative Commons:
/episode/index/show/migraineminute/id/40530130
info_outline
This Treatment Cuts Migraine Days in Diverse Populations
03/06/2026
This Treatment Cuts Migraine Days in Diverse Populations
Analysis of the COMPEL study shows that onabotulinumtoxinA (Botox) can help reduce migraine days, lower migraine-related disability, and improve quality of life in diverse populations of chronic migraine patients. Molly O’Brien breaks down the data in this Migraine Minute News Update. Read More: Researchers acknowledge that the term “race” doesn’t accurately capture diverse cultural differences, noting that future research should distinguish between race and ethnicity. *This content is not sponsored and is intended for educational purposes only. It does not constitute an endorsement by the Association of Migraine Disorders for BOTOX® products.
/episode/index/show/migraineminute/id/40312075
info_outline
Migraine-Related Dizziness? Vestibular Rehab Shows Promise
02/20/2026
Migraine-Related Dizziness? Vestibular Rehab Shows Promise
Can vestibular rehab help vestibular migraine? A new review suggests that it may ease dizziness and improve daily functioning. Molly O’Brien breaks down the information in this Migraine Minute News Update. Read More: Script: A new review published in Headache, The Journal of Head and Face Pain, looked at whether or not vestibular rehabilitation could be effective for vestibular migraine. Researchers looked at seven studies involving more than 400 people with VM. The studies focused on how dizziness affects daily life, using a standardized questionnaire called the Dizziness Handicap Inventory. Overall, people who did vestibular rehab saw improvements in dizziness and quality of life. Results differed from study to study, so additional research is needed to confirm the benefits and figure out which exercises are most helpful.
/episode/index/show/migraineminute/id/39964680
info_outline
Migraine Drug May Help Anxiety, Depression, and Sleep
02/06/2026
Migraine Drug May Help Anxiety, Depression, and Sleep
Migraine preventive treatment benefits may go beyond fewer headache days. A new study links erenumab to improved symptoms of anxiety, depression, and poor sleep quality in some people with migraine. Molly O’Brien has the details in this Migraine Minute News Update. Read More: Script: A new study suggests that one migraine treatment may offer benefits beyond less headache days. Researchers found that the CGRP monoclonal antibody erenumab, sold under the brand name Aimovig, not only reduces migraine frequency… but may improve symptoms of anxiety, depression, and poor sleep quality in some adults with migraine. Participants took 140MG of erenumab monthly. Over the course of the 24 weeks those who had at least a 50 percent drop in monthly migraine days ALSO saw improved anxiety, depression, and sleep quality. The authors say improvements are likely driven by better migraine control rather than a direct effect of the medication. Researchers also say this study highlights how good migraine prevention may improve overall well-being and quality of life.
/episode/index/show/migraineminute/id/39964115
info_outline
Study Reveals Common, Early Migraine Warning Signs
01/23/2026
Study Reveals Common, Early Migraine Warning Signs
In a study published in Headache, researchers identified 36 symptoms that can appear hours before a migraine attack. In this MM news update, Molly O’Brien highlights the most common symptoms, when they occur, and how recognizing these early signs can help people better treat their migraine attacks. Read more: Transcript: A new study published in Headache is among the first to explore the migraine prodrome from the patient's perspective. Researchers held in-depth interviews with 20 people who have migraine, all to better understand what happens before the headache phase begins and how bothersome those symptoms are. The study identified 36 prodrome symptoms…. with nausea, fatigue, sensitivity to light and sound, neck pain/stiffness, irritability, dizziness or vertigo, sensitivity to temperature, brain fog, and trouble concentrating being the most commonly reported. On average, each participant experienced about 13 prodrome symptoms. And, 72% of prodrome symptoms occurred one to six hours before the onset of head pain. The study authors say understanding these early signs may help determine a treatment window…. And if patients can use treatment before severe pain begins, there is potential to reduce migraine burden. That’s your MM news update. I’m Molly O'Brien.
/episode/index/show/migraineminute/id/39650235
info_outline
What the Migraine Community Knows About Migraine Progression
01/09/2026
What the Migraine Community Knows About Migraine Progression
Our recent survey shows some people aren’t aware migraine can progress—and many fear their attacks can get worse. Molly O’Brien breaks down the survey results in this MM news update. Do you worry about pain and symptoms getting worse? Let us know in the comments. Learn more: Transcript: Did you know that migraine can be a progressive disease? For some people, attacks can become more frequent, and symptoms or pain may worsen over time. People may even transition from episodic to chronic migraine. The Association of Migraine Disorders held a survey to see how much the migraine community knows about the potential for progression. Among 459 respondents, 18% did not know that migraine could worsen over time. 50% were aware but hadn’t always realized it could progress or become more severe. 68% said they were moderately to extremely worried that their migraine frequency or severity might increase. While migraine doesn’t get worse for everyone, proper treatment can help prevent progression. If you’re nervous about your attacks getting worse, be sure to talk to your healthcare provider and visit AMD’s treatments page to learn more. That’s your MM news update, I’m Molly O’Brien.
/episode/index/show/migraineminute/id/39650220
info_outline
Update on Migraine Treatment During Pregnancy
12/05/2025
Update on Migraine Treatment During Pregnancy
Treating migraine in pregnancy can be challenging since many drugs carry risks. The good news is that the FDA updated precautions on a drug-free wearable device. Molly O’Brien has the story in this Migraine Minute News Update. Read More: Script: The FDA recently updated its precautionary language on the Nerivio neuromodulation device… removing the note that it has not been studied for use during pregnancy. Based on a 2023 study published in Headache, the FDA changed the precaution to: “Users should consult their healthcare provider if they are pregnant or intend to get pregnant prior to using the device.” As we previously reported in an August 2023 Migraine Minute News update, the study’s results suggest that the Nerivio device is a safe treatment for migraine during pregnancy, does not increase the risk for adverse pregnancy outcomes, and may offer a drug-free treatment option for migraine during pregnancy.
/episode/index/show/migraineminute/id/39170440
info_outline
Study Says Cannabis Shows Promise for Migraine Relief
11/14/2025
Study Says Cannabis Shows Promise for Migraine Relief
First-of-its-kind study: A new study suggests that a combination of THC + CBD works better than placebo, THC alone, or CBD alone for reducing migraine pain and symptoms. Molly O’Brien breaks it down in this Migraine Minute News Update. Read More: Script: For the first time, researchers tested cannabis in a placebo-controlled trial for migraine… and results suggest it could be effective. A recent study found that when treating migraine attacks, a vaporized combination of THC and CBD worked better than THC alone, CBD alone, or a placebo. THC alone helped with pain, but not other symptoms, while CBD alone did not show any benefit. Study participants who used the THC/CBD combination also saw improvements in light and sound sensitivity, but not nausea or vomiting. No serious adverse events were reported. In an interview with MedScape, one researcher noted that people experienced benefits without using higher, recreational doses of cannabis.
/episode/index/show/migraineminute/id/38813165
info_outline
Tried Multiple Migraine Treatments Without Relief? Atogepant May Help
10/31/2025
Tried Multiple Migraine Treatments Without Relief? Atogepant May Help
A new real-world study shows atogepant (sold under brand name Qulipta) may quickly reduce migraine days—even for those who haven’t responded to other treatments. Molly O’Brien has more in this Migraine Minute News Update! Read more: CC License: Script: The GIANT study, published inThe Journal of Headache and Pain, offers real-world evidence that atogepant is a safe, well-tolerated, and effective for migraine prevention—among those whose prior treatments didn’t work. Researchers looked at the impact of 60 mg of atogepant, taken once daily in people with either high-frequency episodic or chronic migraine. Many of the participants had already tried at least three other preventive treatments… including CGRP monoclonal antibodies. Results? At 12 weeks, on average, participants saw a decrease of 6 migraine days and 11 headache days per month. In fact, nearly 60% of experienced at least a 50 percent drop in migraine days. Pain intensity, disability, and use of acute drugs also dropped. Some saw improvement in migraine frequency within the first week.
/episode/index/show/migraineminute/id/38808640
info_outline
Diabetes Drug May Cut Migraine Days in Half
09/19/2025
Diabetes Drug May Cut Migraine Days in Half
Can diabetes and weight loss drugs help with migraine relief? A new study suggests GLP-1 medications may significantly reduce migraine days. @ Molly O’Brien has more in this Migraine Minute News Update. Read More: Image and license to use: Headache. 2025; 00: 1-8. Script: GLP-1s….a drug class widely used for diabetes and weight loss treatment, may also help migraine. A small study published in Headache looked at liraglutide as an add-on treatment for unresponsive migraine in people with obesity who have tried at least two preventive migraine treatments. The study tracked 31 adults with high-frequency episodic or chronic migraine. After taking a daily dose of the drug for three months, on average, they saw monthly headache days drop from about 20 to just under 11—a significant improvement. What may be surprising… is that the benefit came with insignificant weight loss.
/episode/index/show/migraineminute/id/38223550
info_outline
Major Study Shows Triptans Top Other Oral Acute Meds
09/05/2025
Major Study Shows Triptans Top Other Oral Acute Meds
A major study found that oral triptans work better for the acute treatment of migraine, than newer drugs. Molly O’Brien breaks it all down in this Migraine Minute News Update. Read more: Images and License to use: BMJ 2024;386:e080107 Script: A major international study published in the British Medical Journal found triptans to be the most effective acute treatment for migraine. Researchers analyzed 137 clinical trials involving nearly 90,000 adults… comparing 17 oral treatments. They looked at how many people were pain-free two hours post-dose and how many were still pain-free at 24 hours, as well as the safety and tolerability of the treatments. They looked at how many people were pain-free at 2 hours and 24 hours, as well as the safety and tolerability of the treatments. The top performer? Eletriptan — it was shown to be the most effective for both rapid and sustained pain relief. Other high performers included rizatriptan, sumatriptan, and zolmitriptan. Those four triptans consistently outperformed newer acute treatment options like lasmiditan, ubrogepant, and rimegepant. These newer acute treatments worked about as well as acetaminophen and most non-steroidal anti-inflammatory drugs. Also, results showed that not all NSAIDs work the same for migraine.
/episode/index/show/migraineminute/id/38058420
info_outline
Psychedelic Use Linked to Fewer Frequent Headaches
08/15/2025
Psychedelic Use Linked to Fewer Frequent Headaches
A study in the Journal of Psychopharmacology found a surprising connection between psychedelic use and frequent bad headaches. Could psilocybin play a role in headache treatment? Molly O’Brien explains in this Migraine Minute News Update. Read more: Script: A new study in the Journal of Psychopharmacology shows that people who’ve used psychedelics like LSD or psilocybin may be less likely to experience frequent bad headaches. Researchers analyzed data from a large group of people in the UK and found that those who reported a lifetime use of classic psychedelics were 25% less likely to report frequent bad headaches compared to those who had never used them. So why might that be? One thought is that both psychedelics and conventional migraine drugs (like triptans) work on serotonin receptors in the brain. While the study doesn’t prove that psychedelics directly prevent headaches, It DOES add to growing evidence that psychedelics may be a helpful tool to treat headache disorders. And a quick note, psychedelics are illegal on a federal level in the US. That’s your migraine minute news update, I’m Molly O’Brien. Images: Sage Journals. The Journal of Psychopharmacology. doi: 10.1177/02698811251324 License to use:
/episode/index/show/migraineminute/id/37804570
info_outline
How Might Stress Trigger Migraine Pain?
08/01/2025
How Might Stress Trigger Migraine Pain?
Scientists are learning how stress may trigger a series of brain responses that could be linked to migraine, at least in mice. Molly O’Brien has more in this Migraine Minute News Update. Source: Script: A study published in the Journal of Headache and Pain explains how stress can lead to migraine pain. Research in mice found that stress increases a brain chemical called PACAP-38. This chemical activates specific cells that release inflammatory substances. This series of events can affect the trigeminovascular system, which may trigger migraine pain. The study’s author notes that blocking or interrupting this pathway could offer a new way to treat or prevent migraine attacks.
/episode/index/show/migraineminute/id/37348355
info_outline
FDA Approves Two New DHE Migraine Treatments for Fast Relief
07/18/2025
FDA Approves Two New DHE Migraine Treatments for Fast Relief
Two innovative DHE-based migraine treatments just earned FDA approval—offering some Americans new options for managing attacks. Molly O’Brien has details in this #MigraineMinute News Update. Read More: and *DHE is not safe for the management of hemiplegic migraine, migraine with brainstem aura, in people with certain comorbidities, or in those who take certain medications. Script: Many Americans with migraine now have two new treatment options, thanks to recent FDA approvals of Brekiya and Atzumi. Both drugs utilize Dihydroergotamine or DHE. While DHE for migraine has been around for decades, these two new drugs have new delivery methods. Brekiya is the first and only DHE auto-injector approved for the acute treatment of migraine and cluster headache in adults. Atzumi is the first and only DHE nasal powder approved for the acute treatment of migraine with or without aura in adults. It’s important to note that DHE has several safety implications and contraindications and must be prescribed by a healthcare provider.
/episode/index/show/migraineminute/id/37337710
info_outline
Navigating the 4th of July with Migraine: Triggers & Tips
07/04/2025
Navigating the 4th of July with Migraine: Triggers & Tips
Celebrating the Fourth of July with migraine is not easy. The holiday can be packed with sensory overload and migraine triggers. In this Migraine Minute, Molly O’Brien shares tips to help you enjoy the celebration while protecting your health. Check out our updated triggers webpage: Reference: Script: While the Fourth of July can be a fun holiday to celebrate in the States, it can be tough for folks with migraine. Why? Well, there are so many factors that can be stacked against you. Think about it, heat, big crowds, staying up late, BBQ foods and drinks that might have triggering ingredients…Not to mention the bright flashes and loud bangs of fireworks. Research even shows exposure to sulfur dioxide, a common byproduct of fireworks, may trigger migraine attacks. If you have migraine and still want to enjoy the holiday, here are some tips from our migraine community: Stay hydrated, wear ear plugs, watch fireworks from afar or skip all together, bring migraine safe food and drinks to your cook out, wear sunglasses or migraine glasses, and keep a consistent routine. Don’t forget to check out AMD’s updated triggers page, where you can learn more about common migraine triggers and how to manage them.
/episode/index/show/migraineminute/id/37260645
info_outline
Does PACAP 38 Work Differently Than CGRP?
06/06/2025
Does PACAP 38 Work Differently Than CGRP?
New research shows CGRP monoclonal antibody treatment may not prevent migraine attacks triggered by the neuropeptide PACAP-38. This study suggests PACAP-38 may act through a different pathway and could become a future preventive option for people who don’t respond to CGRP-based treatments. Molly O’Brien explains in this Migraine Minute News Update. Read More: Images courtesy: Springer Nature. The Journal of Headache and Pain. doi: 10.1186/s10194-025-02022-2 Creative Commons license: Script: Does PACAP 38 Work Differently Than CGRP? A new study published in the Journal of Headache and Pain found that migraine attacks can be triggered by the neuropeptide PACAP-38 despite pre-treatment with a CGRP monoclonal antibody. Researchers gave 38 participants with migraine an infusion of eptinezumab—a CGRP monoclonal antibody—or placebo, followed by PACAP-38. The results showed no difference in the incidence of migraine attacks between the two groups. This study suggests that PACAP-38 may trigger migraine attacks through a different pathway than CGRP. Treatments targeting PACAP-38 may offer a new preventive option for people who’ve had limited or no success with CGRP monoclonal antibodies.
/episode/index/show/migraineminute/id/36554920
info_outline
Can Erenumab Treat Medication Overuse Headache?
05/23/2025
Can Erenumab Treat Medication Overuse Headache?
A study published in JAMA Neurology shows that monthly erenumab injections may help treat medication overuse headache (MOH) in people with chronic migraine. While the 140 mg dose was effective for treating MOH, the 70 mg dose did not show a meaningful difference compared to placebo. Molly O’Brien explains in this Migraine Minute News Update. Read More: Image Courtesy: JAMA Neurology doi:10.1001/jamaneurol.2024.3043 Transcript: A study published in JAMA Neurology looked at the safety and efficacy of a CGRP monoclonal antibody for treating Medication Overuse Headache in people with chronic migraine. Results show that erenumab– sold under brand name Aimovig- can lead to lasting remission of MOH, reduce the need for pain medication, and improve daily functioning over six months. The study included 584 people with chronic migraine who also had medication overuse headache. At 6 months, 69.1% of those who received 140 mg injections of erenumab monthly no longer met the criteria for medication overuse headache compared to 52.6% of people in the placebo group. It should be noted that the study did not include people who had medication-overuse headache from opioid use.
/episode/index/show/migraineminute/id/36361340
info_outline
Predicting if a Preventive Migraine Treatment Will Work
05/09/2025
Predicting if a Preventive Migraine Treatment Will Work
Most people with migraine go through trial and error to find a preventive treatment that works. But researchers at the Mayo Clinic may have found a way to change that. Using AI, they developed a tool to predict how someone might respond to certain migraine medications—particularly CGRP monoclonal antibodies. Molly O’Brien has more in this Migraine Minute News Update. Read More:
/episode/index/show/migraineminute/id/35953020
info_outline
Can This Preventive Drug Bring Immediate Migraine Relief?
04/25/2025
Can This Preventive Drug Bring Immediate Migraine Relief?
Rapid relief from a preventive migraine treatment? A study published in Neurology shows that one oral gepant medication may start working right away to prevent migraine attacks. Molly O’Brien fills you in, in this Migraine Minute News Update. Read more:
/episode/index/show/migraineminute/id/35952715
info_outline
FDA Approves Axsome’s New Migraine Drug Symbravo®
04/11/2025
FDA Approves Axsome’s New Migraine Drug Symbravo®
The FDA has approved a new drug for the acute treatment of migraine with or without aura in adults. Molly O’Brien has the details and when it becomes available in this Migraine Minute News update. Learn More:
/episode/index/show/migraineminute/id/35952450
info_outline
Can CGRP Blocking Drugs Help Endometriosis?
03/28/2025
Can CGRP Blocking Drugs Help Endometriosis?
Researchers in Boston found that CGRP-blocking drugs commonly used for migraine may help with endometriosis pain and lesion size. Molly O’Brien has the details in this Migraine Minute news update recognizing Endometriosis Awareness Month. Read More: https://bit.ly/4jp0cG2 AMD Comorbidities Library: https://bit.ly/3CIrLtd
/episode/index/show/migraineminute/id/35890315
info_outline
Cluster Headache Often Coexists with Fibromyalgia & Migraine
03/14/2025
Cluster Headache Often Coexists with Fibromyalgia & Migraine
Cluster Headache Awareness Day is March 21st. In this Migraine Minute News Update Molly O’Brien explains findings from a study that found cluster headache, fibromyalgia, and migraine are frequently comorbid conditions. Learn More:
/episode/index/show/migraineminute/id/35366255